Does the frequency of diabetes increase in Covid-19 patients? cross-sectional study

Objective: The aim of this study was to investigate frequency of diabetes mellitus (DM) in patients diagnosed with Covid-19 and whether Covid-19 had effect on high HbA1c. Material-Methods: Data of DM patients with Covid-19 were analyzed cross-sectionally. In Covid-19, the effect of DM patient frequency and mortality was investigated. Results: 2057 patients diagnosed with Covid-19 were included in the study. Among these patients, total 192 patients (9.25%) were treated with the diagnosis of DM. 73 (41 males-32 females) were newly diagnosed with DM (38.02%). 119 patients (48 males and 71 females) were previously diagnosed with DM. Eight of DM patients died. Among all Covid-19 in patients followed up, 90 patients died. Mortality of DM patients was not statistically significant compared to mortality of all patients (p=1.000 x=0). Of the patients who were followed up with diagnosis of DM, whose HbA1c were observed in the last 3 months, 16 of 20 patients had increase in HbA1c, and 4 patients had decrease in HbA1c. The mean increase was 1.05. Conclusion: The frequency of new diagnosis DM in patients with Covid-19 was found to be quite high. There was increase in HbA1c in Covid-19 patients, and Covid-19 was thought to affect the pancreas.